Tofacitinib is an oral inhibitor of Janus kinases that helps treat psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. It is sold under the trade name Xeljanz. It is a long-term treatment where improvement can be seen after the first 12 weeks of treatment. Doctors avoid this medication for pregnant women or planning for a baby. Your healthcare professional will conduct a blood test to check your condition whether medication suits you.Tofacitinib 5 mg pricemay vary depending on the different wholesalers or brands available in the market.